- Home
- UEIC vs SER Comparison
UEIC vs SER Comparison
Compare UEIC & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UEIC
- SER
- Stock Information
- Founded
- UEIC 1986
- SER 2017
- Country
- UEIC United States
- SER United States
- Employees
- UEIC N/A
- SER N/A
- Industry
- UEIC Consumer Electronics/Appliances
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- UEIC Consumer Staples
- SER Health Care
- Exchange
- UEIC Nasdaq
- SER Nasdaq
- Market Cap
- UEIC 47.7M
- SER 41.2M
- IPO Year
- UEIC 1993
- SER 2018
- Fundamental
- Price
- UEIC $3.54
- SER $3.96
- Analyst Decision
- UEIC Buy
- SER Strong Buy
- Analyst Count
- UEIC 2
- SER 2
- Target Price
- UEIC $10.00
- SER $13.00
- AVG Volume (30 Days)
- UEIC 97.2K
- SER 29.6K
- Earning Date
- UEIC 11-06-2025
- SER 11-11-2025
- Dividend Yield
- UEIC N/A
- SER N/A
- EPS Growth
- UEIC N/A
- SER N/A
- EPS
- UEIC N/A
- SER N/A
- Revenue
- UEIC $390,997,000.00
- SER $130,000.00
- Revenue This Year
- UEIC $0.57
- SER $134.46
- Revenue Next Year
- UEIC N/A
- SER N/A
- P/E Ratio
- UEIC N/A
- SER N/A
- Revenue Growth
- UEIC 2.35
- SER N/A
- 52 Week Low
- UEIC $3.03
- SER $3.70
- 52 Week High
- UEIC $12.50
- SER $7.92
- Technical
- Relative Strength Index (RSI)
- UEIC 26.82
- SER 29.95
- Support Level
- UEIC $4.34
- SER $4.60
- Resistance Level
- UEIC $3.96
- SER $5.00
- Average True Range (ATR)
- UEIC 0.21
- SER 0.29
- MACD
- UEIC -0.07
- SER -0.11
- Stochastic Oscillator
- UEIC 31.72
- SER 16.40
About UEIC Universal Electronics Inc.
Universal Electronics Inc is a United States-based company that principally designs, develops, manufactures, ships, and supports control and sensor technology solutions and a broad line of universal control systems, audio-video (AV) accessories, wireless security, and smart home products that are used by the world's brands in the video services, consumer electronics, security, home automation, climate control and home appliance markets. It generates its total revenue from the United States.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.